The Company is a Korea-based company principally engaged in the new drug development business. The Company is principally engaged in the research and development of new cancer antibody drugs for small cell lung cancer, liver cancer, solid cancer as well as others. The Company was established on December 31, 2007. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on December 5, 2023.
Headquarters
B715, 17, Techno 4-Ro, Yuseong-Gu
Daejeon; Daejeon;
Contact Details: Purchase the Y-Biologics Inc. report to view the information.
Website: http://ybiologics.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service